3',5'-cyclic-AMP phosphodiesterase 4D

PDE4D encodes a cyclic nucleotide phosphodiesterase that hydrolyzes the second messenger cAMP, a key regulator of numerous physiological processes (UniProt: Q08499). The protein is implicated in acrodysostosis 2 (ACRDYS2), a pleiotropic disorder featuring skeletal abnormalities, endocrine dysfunction, and variable developmental disability.

In Alzheimer's Disease research, PDE4D is consistently down-regulated in post-mortem AD brain tissue compared to age-matched controls, with a mean log2 fold-change of −0.43 across subcellular fractions (Chaparral AD proteomics). This down-regulation was detected via TMT-labeled proteomics across multiple subcellular compartments (P2, P3, S2, S3 fractions), suggesting a broader reduction in cAMP-degrading capacity in AD brain. The functional significance of diminished PDE4D in AD pathology remains to be clarified, but altered cAMP signaling has been implicated in neurodegenerative processes.